ovarian cancer

ASCO20 Virtual Scientific Program: #ASCO20
May 13, 2020 · Leslie Fannon Zhang, ASCO staff
Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers. Read More >>
ASCO20 Virtual Scientific Program: #ASCO20
May 13, 2020 · Leslie Fannon Zhang, ASCO staff
Lea los puntos destacados iniciales de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Estos incluyen estudios sobre dejar de fumar y la supervivencia al cáncer de pulmón, el tratamiento del cáncer de ovario recurrente, la evaluación geriátrica para los pacientes que están recibiendo terapia sistémica, cómo la ampliación de Medicaid afecta a la mortalidad por cáncer en EE. UU. y el uso de videoconferencias con los cuidadores a distancia. Read More >>
Ricardo Cubedo, MD
November 14, 2019 · Greg Guthrie, ASCO staff
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
2019 ASCO ® Annual Meeting; #ASCO19
June 2, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care. Read More >>
May 10, 2019 · Claire Smith, ASCO staff
Kimberly Pena was 31 when she was diagnosed with breast cancer, the same age her mother was when she was diagnosed more than 3 decades earlier. She shares her experience with cancer, treatment, and trying to convince her family to be tested for the BRCA genetic mutation. Read More >>

Pages